Skip to main content

Advertisement

SpringerLink
Log in

Osteoporosis in inflammatory joint diseases

  • Review
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are two inflammatory joint diseases characterized by bone complications including osteoporosis. In RA, periarticular bone loss, bone erosions, and systemic osteoporosis are observed, with an increased risk of fractures. Determinants of fractures are underlying conditions (as RA has a female preponderance and an increased prevalence with age), severity of the disease, and use of glucocorticoids. However, bone loss can occur even in glucocorticoid-naive patients. Prospective data show that the optimal control of inflammation in RA is associated with decrease in structural damage and bone loss. RA illustrates the role of inflammation on bone resorption. In AS, osteoporosis is an early event and vertebral fracture risk is increased. Bone loss is related mainly to inflammation, as the disease can occur in young male adult populations, and glucocorticoids are not used in this disease. However, AS is characterized by progressive stiffness and ankylosis of the spine and illustrates also the potential role of inflammation on local bone formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. van Staa TP, Geusens P, Bijlsma WJ, Leufkens HGM, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104–3112

    Article  PubMed  Google Scholar 

  2. Orstavik RE, Haugeberg G, Uhlig T, Mowinckel P, Falch JA, Halse JI et al (2004) Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis 63:177–182

    Article  CAS  PubMed  Google Scholar 

  3. Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R (2001) Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis 60:521–522

    Article  CAS  PubMed  Google Scholar 

  4. Hooyman JR, Melton LJ, Nelson AM, O’Fallon WM, Riggs BL (1984) Fractures after rheumatoid arthritis. Arthritis Rheum 27:1353–1361

    Article  CAS  PubMed  Google Scholar 

  5. Orstavik RE, Haugeberg G, Mowinckel P, Hoiseth A, Uhlig T, Falch JA, Halse JI, Mc Closkey E, Kvien TK (2004) Vertebral deformities in rheumatoid arthritis. Arch Intern Med 164:420–425

    Article  PubMed  Google Scholar 

  6. de Nijs RNJ, Jacobs JWG, Bijlsma JWJ, Lems WF, Laan RFJM, Houben HHM, ter Borg EJ, Huisman AM, Bruyn GAW, van Oijen PLM, Westgeest AAA, Algra A, Hofman DM, on behalf of the Osteoporosis Working Group of the Dutch Society for Rheumatology (2001) Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology 40:1375–1383

    Article  PubMed  Google Scholar 

  7. Spector TD, Hall GM, Mc Closkey EV, Kanis JA (1993) Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 306:558

    Article  CAS  PubMed  Google Scholar 

  8. Pell NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801–806

    Article  Google Scholar 

  9. Orstavik RE, Haugeberg G, Uhlig T, Mowinckel P, Falch JA, Halse JI, Kvien T (2005) Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry. Osteoporos Int 16:35–42

    Article  PubMed  Google Scholar 

  10. Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ et al (2003) Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo–Truro–Amsterdam (OSTRA) collaborative study. Arthritis Rheum 49:209–215

    Article  PubMed  Google Scholar 

  11. Lems WF, Jahangier ZN, Jacobs JWG, Bijlsma JWJ (1995) Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol 13:293–297

    CAS  PubMed  Google Scholar 

  12. Ursum J, Britsemmer K, van Schaardenburg D, Lips PTA, Dijkmans BAC, Lems W (2009) High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis. Ann Rheum Dis 68:1512–1513

    Article  CAS  PubMed  Google Scholar 

  13. Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, Frediano B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S (2000) High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 27:2582–2589

    CAS  PubMed  Google Scholar 

  14. Smulders E, Schreven C, Weerdesteyn V et al (2009) Fall incidence and fall risk factors in people with rheumatoid arthritis. Ann Rheum Dis 68:1795–1796

    Article  CAS  PubMed  Google Scholar 

  15. Hayashibara M, Hagino H, Katagiri H, Okano T, Okada J, Teshima R (2010) Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: a prospective 1-year study. Osteoporos Int. doi:10.1007/s00198-009-1150-4

  16. Jamison M, Neuberger GB, Miller PA (2003) Correlates of falls and fear of falling among adults with rheumatoid arthritis. Arthritis Rheum 49:673–680

    Article  PubMed  Google Scholar 

  17. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B et al (1994) Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93:2379–2386

    Article  CAS  PubMed  Google Scholar 

  18. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, Muller D, Fontaine KR, Bathon JM (2008) Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 59:807–815

    Article  PubMed  Google Scholar 

  19. Matschke V, Murphy P, Lemmey AB, Maddison PJ, Thom JM (2010) Muscle quality, architecture, and activation in cachetic patients with rheumatoid arthritis. J Rheumatol 37:282–284

    Article  PubMed  Google Scholar 

  20. Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ (2006) Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 84:1463–1472

    CAS  PubMed  Google Scholar 

  21. Marcora SM, Lemmey AB, Maddison PJ (2005) Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study. J Rheumatol 32:1031–1039

    PubMed  Google Scholar 

  22. Orstavik RE, Haugeberg G, Uhlig T, Falch JA, Halse JI, Hoiseth A, Lilleas F, Kvien TK (2003) Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density. Arthritis Rheum 3:355–360

    Article  Google Scholar 

  23. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 43:522–530

    Article  CAS  PubMed  Google Scholar 

  24. Martin JC, Munro R, Campbell MK, Reid DM (1997) Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 36:43–49

    Article  CAS  PubMed  Google Scholar 

  25. Hall GM, Spector TD, Griffin AJ, Jawad ASM, Hall ML, Doyle DV (1993) The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 36:1510–1516

    Article  CAS  PubMed  Google Scholar 

  26. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S (1987) Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 30:721–728

    Article  CAS  PubMed  Google Scholar 

  27. Kroger H, Honkanen R, Saarikoski S, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis—a population based study. Ann Rheum Dis 53:18–23

    Article  CAS  PubMed  Google Scholar 

  28. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Reduced bone mineral density in male rheumatoid arthritis patients. Arthritis Rheum 43:2776–2784

    Article  CAS  PubMed  Google Scholar 

  29. Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23–27

    Article  CAS  PubMed  Google Scholar 

  30. Lodder MC, de Jong Z, Kostense PJ, Molenaar ETH, Staal K, Voskuyl AE, Hazes JMW, Dijkmans BAC, Lems WF (2004) Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 63:1576–1580

    Article  CAS  PubMed  Google Scholar 

  31. Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Ronday HK, Peeters AJ, de Jonge-Bok JM, Breedveld FC, Dijkmans BAC, Allaart CF, Lems WF (2007) Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis 66:1508–1512

    Article  PubMed  Google Scholar 

  32. Forslind K, Keller C, Svensson B, Hafstrom I (2003) Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women. J Rheumatol 30:2590–2596

    PubMed  Google Scholar 

  33. Kroot EJJA, Nieuwenhuizen MG, Waal Malefijt MC de, Riel PLCM van, Pasker-de Jong PCM van, Laan RFJM (2001) Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum 44:1254–1260

    Article  CAS  PubMed  Google Scholar 

  34. Chopin F, Garnéro P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T (2008) Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis 67:353–357

    Article  CAS  PubMed  Google Scholar 

  35. Haugeberg G, Conaghan PG, Quinn M, Emery P (2009) Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study. Ann Rheum Dis 68:1898–1901

    Article  CAS  PubMed  Google Scholar 

  36. Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BAC, Woolf AD, Kvien TK, Lems WF (2006) Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 65:1495–1499

    Article  CAS  PubMed  Google Scholar 

  37. Wijbrandts CA, Klaasen R, Dijkgraaf MGW, Gerlag DM, van Eck-Smit BLF, Tak PP (2009) Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis 68:373–376

    Article  CAS  PubMed  Google Scholar 

  38. Haugeberg G, Strand A, Kvien TK et al (2005) Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo controlled trial. Arch Intern Med 165:1293–1297

    Article  PubMed  Google Scholar 

  39. Peel NFA, Spittlehouse AJ, Bax DE, Eastell R (1994) Bone mineral density of the hand in rheumatoid arthritis. Arthritis Rheum 5:983–991

    Article  Google Scholar 

  40. Deodhar AA, Brabyn J, Pande I, Scott DL, Woolf AD (2003) Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker. Ann Rheum Dis 62:767–770

    Article  CAS  PubMed  Google Scholar 

  41. Haugeberg G, Green MJ, Quinn MA, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, Conaghan PG, Stewart S, Emery P (2006) Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 65:736–740

    Article  CAS  PubMed  Google Scholar 

  42. Jensen T, Klarlund M, Hansen M, Jensen KE, Podenphant J, Hansen TM, Skjodt H, Hydstrup L (2004) Bone loss unclassified polyarthritis and early rheumatoid arthritis is better detected by digital X-ray radiogrammetry than dual X-ray absorptiometry: relationship with disease activity and radiographic outcome. Ann Rheum Dis 63:15–22

    Article  CAS  PubMed  Google Scholar 

  43. Bottcher J, Pfeil A, Rosholm A, Petrovitch A, Seidl BE, Malich A, Schafer ML, Kramer A, Mentzel HJ, Lehmann G et al (2005) Digital X-ray radiogrammetry combined with semiautomated analysis of joint space widths as a new diagnostic approach in rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Rheum 52:3850–3859

    Article  CAS  PubMed  Google Scholar 

  44. Haugeberg G, Green MJ, Conaghan PG, Quinn M, Wakefield R, Proudman SM, Stewart S, Hensor E, Emery P (2007) Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis. Ann Rheum Dis 66:1513–1517

    Article  CAS  PubMed  Google Scholar 

  45. Hoff M, Haugeberg G, Kvien TK (2007) Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss. Arthritis Res Ther 9:1–8

    Article  Google Scholar 

  46. Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J (2000) Detailed analyses in periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int 11:400–407

    Article  CAS  PubMed  Google Scholar 

  47. Lindqvist E, Jonsson K, Saxne T, Eberhardt K (2003) Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 62:611–616

    Article  CAS  PubMed  Google Scholar 

  48. Hoff M, Haugeberg G, Odegard S, Syversen S, Landewé R, van der Heijde D, Kvien TK (2009) Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis 68:324–329

    Article  CAS  PubMed  Google Scholar 

  49. Güler-Yüksel M, Allaart CF, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, van Groenendael JHLM, Mallée C, de Bois MHW, Breedveld FC, Dijkmans BAC, Lems WF (2009) Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 68:330–336

    Article  PubMed  Google Scholar 

  50. Boyesen P, Hoff M, Odegard S, Haugeberg G, Syversen SW, Gaarder PI, Okkenhaug C, Kvien TK (2009) Antibodies to cyclic citrillunated protein and ESR predict hand bone loss in patients with RA of short duration. Arthritis Res Ther 11:R103

    Article  PubMed  CAS  Google Scholar 

  51. Stach CM, Bäuerle M, Englbrecht M, Kronke G, Engelke K, Manger B, Schett G (2010) Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography. Arthritis Rheum 62:330–339

    PubMed  Google Scholar 

  52. Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA (2004) Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 50:36–42

    Article  PubMed  Google Scholar 

  53. Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, Petrangeli M, Oberhollenzer F, Lorenzini R, Redlich K, Axmann R, Zwerina J, Willeit J (2006) High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 166:2495–2501

    Article  CAS  PubMed  Google Scholar 

  54. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G (2008) Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93:1952–1958

    Article  CAS  PubMed  Google Scholar 

  55. Cauley JA, Danielson ME, Boudreau RM, Forrest KYZ, Zmuda J, Pahor M, Tylavsky FA, Cummings SR, Harris TB, Newman AB, for the Health ABC study (2007) Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 22:1088–1095

    Article  CAS  PubMed  Google Scholar 

  56. Charactcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL (2007) Effect of blockade of TNF-α and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724–729

    Article  Google Scholar 

  57. Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B (1998) Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 25:2339–2344

    CAS  PubMed  Google Scholar 

  58. Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, Nguyen T, Emery P (1998) Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 25:1282–1289

    CAS  PubMed  Google Scholar 

  59. Garnéro P, Landewe R, Boers M, Verhoeven A, van der Linden S, Christgau S, van der Heijde D, Boonen A, Geusens P (2002) Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis. The Cobra Study. Arthritis Rheum 46:2847–2856

    Article  PubMed  CAS  Google Scholar 

  60. Geusens PP, Landewé RBM, Garnéro P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DMFM, van der Linden S, Boers M (2006) The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 54:1772–1777

    Article  CAS  PubMed  Google Scholar 

  61. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G (2002) Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 110:1419–1427

    CAS  PubMed  Google Scholar 

  62. Jimenez-Boj E, Redlich K, Türk B, Hanslik-Schnabel H, Wanivenhaus A, Chott A, Smolen JS, Schett G (2005) Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J Immunol 175:2579–2588

    CAS  PubMed  Google Scholar 

  63. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoproteogerin ligand. Nature 402:304–309

    Article  CAS  PubMed  Google Scholar 

  64. Zaiss MM, Axmann R, Zwerina J, Polzer K, Gückel E, Skapenko A, Schulze-Koops H, Horwood N, Cope A, Schett G (2007) Treg cells suppress ostoclast formation. A new link between the immune system and bone. Arthritis Rheum 56:4104–4112

    Article  CAS  PubMed  Google Scholar 

  65. Axmann R, Herman S, Zaiss M, Franz S, Polzer K, Zwerina J, Hermann M, Smolen J, Schett G (2008) CTLA-4 directly inhibits osteoclast formation. Ann Rheum Dis 67:1603–1609

    Article  CAS  PubMed  Google Scholar 

  66. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673–2682

    Article  CAS  PubMed  Google Scholar 

  67. Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM (2006) RANKL protein is expressed at the pannus–bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology 45:1068–1076

    Article  CAS  PubMed  Google Scholar 

  68. Li C, Wei XQ, Evans B, Jiang W, Aeschlimann D (2008) IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kb (RANK) expression in myeloid precursor cells. Eur J Immunol 38:2845–2854

    Article  CAS  Google Scholar 

  69. Herman S, Mueller R, Kronke G, Zwerina J, Redlich K, Hueber A, Gelse H, Neumann E, Mueller-Ladner U, Schett G (2008) OSCAR, a key co-stimulation molecule for osteoclasts, is induced in patients with rheumatoid arthritis. Arthritis Rheum 58:3041–3050

    Article  CAS  PubMed  Google Scholar 

  70. Schett G, Redlich K, Hayer S et al (2003) Osteoproteogerin protects against generalized bon loss in tumor necrosis factor-transgenic mice. Arthritis Rheum 48:2042–2051

    Article  CAS  PubMed  Google Scholar 

  71. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNFα induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligang. J Clin Invest 106:1481–1488

    Article  CAS  PubMed  Google Scholar 

  72. Polzer K, Joosten L, Gasser J, Distler JH, Ruiz G, Baum W, Redlich K, Bobacz K, Smolen JS, van den Berg W, Schett G, Zwerina J (2010) Interleudin-1 is essential for systemic inflammatory bone loss. Ann Rheum Dis 69:284–290

    Article  CAS  PubMed  Google Scholar 

  73. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewé R, Lacey D, Richard WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156–163

    Article  CAS  PubMed  Google Scholar 

  74. Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, Gravallese EM (2009) Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 24:1572–1585

    Article  CAS  PubMed  Google Scholar 

  75. Axmann R, Böhm C, Krönke G, Zwerina J, Smolen J, Schett G (2009) Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum 60:2747–2756

    Article  CAS  PubMed  Google Scholar 

  76. Saidenberg-Kermanac’h N, Corrado A, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal M (2004) TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 35:1200–1207

    Article  PubMed  CAS  Google Scholar 

  77. Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, Duryea D, Pacheco E, Van G, Bolon B, Feige U, Zack D, Kostenuik P (2009) RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies. Arthritis Res Ther 11:11–15

    Article  CAS  Google Scholar 

  78. Haynes D, Crotti T, Weedon H, Slavotinek J, Au V, Coleman M, Roberts-Thomson PJ, Ahern M, Smith MD (2008) Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome. Arthritis Rheum 59:911–920

    Article  CAS  PubMed  Google Scholar 

  79. Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R, on behalf of the Denosumab Rheumatoid Arthritis Study Group (2008) Denosumab treatment effects on strutural damage, bone mineral density, and bone turnover in rheumatoid arthritis. Arthritis Rheum 58:1299–1309

    Article  CAS  PubMed  Google Scholar 

  80. Will R, Palmer R, Bhalla AK, Ring F, Calin A (1989) Osteoporosis in early ankylosing spondylitis. A primary pathological event? Lancet ii:1483–1485

    Article  Google Scholar 

  81. Maillefert JF, Aho S, El Maghraoui A, Dougados M, Roux C (2001) Changes in bone density in patients with ankylosing spondylitis: a 2 year follow-up study. Osteoporos Int 12:605–609

    Article  CAS  PubMed  Google Scholar 

  82. Geusens P, Vosse D, van der Heijde DM et al (2001) High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis. J Rheumatol 28:1856–1861

    CAS  PubMed  Google Scholar 

  83. Raltson SH, Urquhart GDK, Bzeski M, Sturrock RD (1990) Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. Br Med J 300:563–565

    Article  Google Scholar 

  84. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon WM, Melton LJ (1994) Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 21:1877–1882

    CAS  PubMed  Google Scholar 

  85. Donnelly S, Doyle DV, Denton A, Rolfe J, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121

    Article  CAS  PubMed  Google Scholar 

  86. Mitra D, Elvins DM, Speden DJ et al (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 39:85–89

    Article  CAS  PubMed  Google Scholar 

  87. Vosse D, Feidtkeller E, Erlendsson J et al (2004) Clinical vertebral fractures in patients with ankylosing spondylitis. J Rheumatol 31:1981–1985

    PubMed  Google Scholar 

  88. Feldtkeller E, Vosse D, Geusens P, van der Linden S (2006) Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis. Rheumatol Int 26:234–239

    Article  PubMed  Google Scholar 

  89. Vosse D, Landewé R, van der Heijde D, van der Linden S, van Staa TP, Geusens P (2009) Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case–control study. Ann Rheum Dis 68:1839–1842

    Article  CAS  PubMed  Google Scholar 

  90. Devogelaer JP, Maldague B, Malghem J, Nagant de Deuxchaisnes C (1992) Appendicular and vertebral bone mass in ankylosing spondylitis. Arthritis Rheum 35:1062–1067

    Article  CAS  PubMed  Google Scholar 

  91. Jun JB, Joo KB, Her MY, Kim TH, Bae SC, Yoo DH, Kim SK (2006) Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 33:1637–1641

    PubMed  Google Scholar 

  92. El Maghraoui A, Borderie D, Edouard R, Roux C, Dougados M (1999) Osteoporosis, body composition and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209

    CAS  PubMed  Google Scholar 

  93. Toussirot E, Michel F, Wendling D (2001) Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology 40:882–888

    Article  CAS  PubMed  Google Scholar 

  94. Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, Bezza A, Maghraoui A El (2009) Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 44:772–776

    Article  CAS  PubMed  Google Scholar 

  95. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32:1290–1298

    PubMed  Google Scholar 

  96. Obermayer-Pietsch BM, Lange U, Tauber G et al (2003) Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis. Osteoporos Int 14:995–1000

    Article  CAS  PubMed  Google Scholar 

  97. Gratacos J, Collado A, Pons F, Osaba M, Sammarti R, Roqué M et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis. A follow-up study. Arthritis Rheum 42:2319–2324

    Article  CAS  PubMed  Google Scholar 

  98. Visvanathan S, van der Heijde D, Deodhar A, Wagner C, Baker DG, Han J, Braun J (2009) Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 68:175–182

    Article  CAS  PubMed  Google Scholar 

  99. Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C (2003) Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis 62:347–349

    Article  CAS  PubMed  Google Scholar 

  100. Briot K, Gossec L, Kolta S, Dougados M, Roux C (2008) Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-α treatment. J Rheumatol 35:855–861

    CAS  PubMed  Google Scholar 

  101. Vosse D, Landewé R, Garnéro P, van der Heijde D, van der Linden S, Geusens P (2008) Association of markers of bone – and cartilage – degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis. Rheumatology 1-4

  102. MacDonald AG, Birkinshaw G, Durham B, Bucknall RC, Fraser WD (1997) Biomedical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheum 36:50–53

    Article  CAS  Google Scholar 

  103. Stupphann D, Ranner M, Krenbeck D et al (2008) Intracellular and surface RANK L are differentially regulated in patients with ankylosing spondylitis. Rheumatol Int 28:987–993

    Article  CAS  PubMed  Google Scholar 

  104. Rauner M, Stupphann D, Haas M, Fert I, Glatigny S, Sipos W, Bréban M, Pietschmann P (2009) The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio. J Rheumatol 36:120–126

    PubMed  Google Scholar 

  105. Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RGW (2009) Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 60:93–102

    Article  PubMed  Google Scholar 

  106. Lories RJU, Derese I, Luyten FP (2005) Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 115:1571–1579

    Article  CAS  PubMed  Google Scholar 

  107. Lories RJ, Derese I, Ceuppens JL, Luyten FP (2003) Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by pro inflammatory cytokines, and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48:2807–2818

    Article  CAS  PubMed  Google Scholar 

  108. Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G (2009) Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 60:3257–3262

    Article  PubMed  Google Scholar 

  109. Schett G, Stolina M, Dwyer D, Zack D, Uderhardt S, Krönke G, Kostenuik P, Feige U (2009) Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. Arthritis Rheum 60:2644–2654

    Article  CAS  PubMed  Google Scholar 

  110. Uderhardt S, Diarra D, Katzenbeisser J, David JP, Zwerina J, Richards WG, Krönke G, Schett G (2010) Blockade of dickkopf-1 induces fusion of sacroiliac joints. Ann Rheum Dis 69:592–597

    Article  CAS  PubMed  Google Scholar 

  111. Daoussis D, Liossis SNC, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP (2010) Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62:150–158

    Article  CAS  PubMed  Google Scholar 

  112. Mc Gonagle D, Wakefield RJ, Tan AL, D’agostino MA, Toumi H, Hayashi K, Emery P, Benjamin M (2008) Distinct topography of erosion and new bone formation in Achilles tendon enthesitis. Implications for understanding the link between inflammation and bone formation in spondylarthritis. Arthritis Rheum 58:2694–2699

    Article  Google Scholar 

  113. Lories RJU, Derese I, De Bari C, Luyten FP (2007) Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 56:489–497

    Article  PubMed  Google Scholar 

  114. Iwasawa T, Iwasaki K, Sawada T, Okada A, Ueyama K, Motomura S, Harata S, Inoue I, Toh S, Furukawa KI (2006) Pathophysiological role of endothelin in ectopic ossification of human spinal ligaments induced by mechanical stress. Calcif Tissue Int 79:422–430

    Article  CAS  PubMed  Google Scholar 

  115. Clines GA, Mohammad KS, Bao Y, Stephens OW, Suva LJ, Shaughnessy JD, Fox JW, Chirgwin JM, Guise TA (2007) Dickkopf homolog 1 mediates endothelin-1 stimulated new bone formation. Mol Endocrinol 21:486–498

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Rheumatology Department, Cochin Hospital, Paris Descartes University, Paris, France

    C. Roux

Authors
  1. C. Roux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Roux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roux, C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 22, 421–433 (2011). https://doi.org/10.1007/s00198-010-1319-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-010-1319-x

Keywords

Search

Navigation